We are live on ! Find out more
FRTX

Fresh Tracks Therapeutics, Inc. Common Stock
FRTX

Delisted

FRTX was delisted on the 18th of December, 2023.

Back to rankings

15 hedge funds and large institutions have $69.8K invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 18 → 15 (-3)

28% less capital invested

Capital invested by funds: $97.3K → $69.8K (-$27.4K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$670
2
Wells Fargo
Wells Fargo
California
+$14

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$14K
2
VF
Virtu Financial
New York
-$10.6K
3
UBS Group
UBS Group
Switzerland
-$4.26K
4
CSS
Cubist Systematic Strategies
Connecticut
-$2.14K
5
TRCT
Tower Research Capital (TRC)
New York
-$5
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$16.2K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$10.3K – – –
VF
3
Virtu Financial
New York
$9K -$10.6K -17,458 -58%
TSS
4
Two Sigma Securities
New York
$7.94K +$670 +1,102 +11%
TRCT
5
Tower Research Capital (TRC)
New York
$7.34K -$5 -9 -0.1%
CSS
6
Cubist Systematic Strategies
Connecticut
$7.1K -$2.14K -3,517 -26%
SCM
7
Silverarc Capital Management
Massachusetts
$7.01K – – –
BlackRock
8
BlackRock
New York
$3.36K – – –
BTI
9
Blue Trust Inc
Georgia
$1K – – –
SPIA
10
Steward Partners Investment Advisory
New York
$497 – – –
Wells Fargo
11
Wells Fargo
California
$100 +$14 +23 +19%
Osaic Holdings
12
Osaic Holdings
Arizona
$30 – – –
JWA
13
JFS Wealth Advisors
Pennsylvania
$16 – – –
Bank of America
14
Bank of America
North Carolina
$2 – – –
Millennium Management
15
Millennium Management
New York
– -$14K -20,912 Closed
UBS Group
16
UBS Group
Switzerland
– -$4.26K -6,462 Closed
Point72 Asset Management
17
Point72 Asset Management
Connecticut
– -$1 -1 Closed

FRTX Hedge Fund Activity: Q2 2023 in Review

15 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2023, worth a combined $69.8K — down 28% from $97.3K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of FRTX and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Two Sigma Securities, adding an estimated $670. The largest seller was Millennium Management, exiting entirely with an estimated $14K sold.

  • 15 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2023, down from 18 in Q1 2023.
  • Funds reported $69.8K of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2023, down 28% quarter-over-quarter.
  • 0 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2023 and 3 closed out, a net change of -3 holders.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2023 was Two Sigma Securities, an estimated $670 added.
  • The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2023 was Millennium Management, an estimated $14K sold.

Based on aggregated 13F filings for Q2 2023.